These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 20233083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
    Xiong XB, Mahmud A, Uludağ H, Lavasanifar A.
    Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
    [Abstract] [Full Text] [Related]

  • 4. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O, van Nostrum CF, Fens M, Rijcken CJ, Schiffelers RM, Storm G, Hennink WE.
    J Control Release; 2005 Mar 21; 103(2):341-53. PubMed ID: 15763618
    [Abstract] [Full Text] [Related]

  • 5. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X, Sha X, Xin H, Chen L, Gao X, Wang X, Law K, Gu J, Chen Y, Jiang Y, Ren X, Ren Q, Fang X.
    Biomaterials; 2011 Dec 21; 32(35):9457-69. PubMed ID: 21911250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells.
    Cai L, Qiu N, Li X, Luo K, Chen X, Yang L, He G, Wei Y, Chen L.
    Int J Pharm; 2011 Apr 15; 408(1-2):173-82. PubMed ID: 21277964
    [Abstract] [Full Text] [Related]

  • 8. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
    Wang Y, Wang X, Zhang Y, Yang S, Wang J, Zhang X, Zhang Q.
    J Drug Target; 2009 Jul 15; 17(6):459-67. PubMed ID: 19527117
    [Abstract] [Full Text] [Related]

  • 9. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
    Shahin M, Ahmed S, Kaur K, Lavasanifar A.
    Biomaterials; 2011 Aug 15; 32(22):5123-33. PubMed ID: 21501865
    [Abstract] [Full Text] [Related]

  • 10. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C, Wei X, Qian J, Feng L, Zhu J, Lu W.
    J Control Release; 2012 Jun 28; 160(3):630-6. PubMed ID: 22410115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.
    Mishra GP, Nguyen D, Alani AW.
    Mol Pharm; 2013 May 06; 10(5):2071-8. PubMed ID: 23590802
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
    Yuan ZQ, Li JZ, Liu Y, Chen WL, Yang SD, Zhang CG, Zhu WJ, Zhou XF, Liu C, Zhang XN.
    Int J Pharm; 2015 Aug 15; 492(1-2):141-51. PubMed ID: 26188316
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature.
    Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q.
    Nanomedicine; 2012 Jan 15; 8(1):81-92. PubMed ID: 21664295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, Préat V.
    Eur J Pharm Biopharm; 2009 Oct 15; 73(2):230-8. PubMed ID: 19577643
    [Abstract] [Full Text] [Related]

  • 20. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X, Wang X, Wang Y, Yang L, Hu J, Xiao W, Fu A, Cai L, Li X, Ye X, Liu Y, Wu W, Shao X, Mao Y, Wei Y, Chen L.
    J Control Release; 2010 Jul 01; 145(1):17-25. PubMed ID: 20307599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.